Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T04:06:04.486Z Has data issue: false hasContentIssue false

Increased risk of Enterococcal Bacteremia in critically ill patients with COVID-19 during pandemic surges

Published online by Cambridge University Press:  15 September 2025

Sharanjeet K. Thind*
Affiliation:
Section of Infectious Diseases, Medical Service, Oklahoma City VA Healthcare System, Oklahoma City, OK, USADepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Ghias N. Sheikh
Affiliation:
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USASection of Pulmonary, Critical Care and Sleep Medicine, Oklahoma City VA Healthcare System, Oklahoma City, OK, USA
Syeda Sahra
Affiliation:
Section of Infectious Diseases, Medical Service, Oklahoma City VA Healthcare System, Oklahoma City, OK, USADepartment of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Dena R. Shibib
Affiliation:
Department of Pathology, Oklahoma City VA Health Care System, Oklahoma City, OK, USADepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
Awais Bajwa
Affiliation:
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USASection of Pulmonary, Critical Care and Sleep Medicine, Oklahoma City VA Healthcare System, Oklahoma City, OK, USA
Houssein A. Youness
Affiliation:
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USASection of Pulmonary, Critical Care and Sleep Medicine, Oklahoma City VA Healthcare System, Oklahoma City, OK, USA
Chris A. Gentry
Affiliation:
Pharmacy Service, Oklahoma City VA Health Care System, Oklahoma City, OK, USA
*
Corresponding author: Sharanjeet K. Thind; Email: sharanjeet-thind@ouhsc.edu

Abstract

Objective:

Identify incidence of enterococcal bacteremia and associated risk factors in ICU patients with SARS-CoV-2 infection.

Design:

Retrospective cohort study.

Setting:

Veterans Affairs Medical Center, Oklahoma City, Oklahoma.

Patients:

Adult ICU patients with SARS-CoV-2 and positive blood cultures for Enterococcus species between March 1, 2020 and February 28, 2022.

Methods:

Durations of hospitalization, ICU stay, ventilation, site and duration of central line, receipt of steroids, tocilizumab, and antimicrobials were gathered by chart review. Patient location during a surge of bacteremia was noted and strains were identified by multilocus sequencing typing (MLST).

Results:

There were 70 episodes of enterococcal bacteremia in ICU patients with COVID-19 during a 2-year period. Patients had a median age of 72 years and 97% were male. Onset of bacteremia was 12 and 14 days after mechanical ventilation and central line placement, respectively. The median number of days to bacteremia diagnosis was 13 from admission to the ICU and 90-day mortality was 66.7% among patients admitted October to December of 2020. A large proportion of ICU patients developed enterococcal bacteremia during a COVID-19 surge (P < .00001) and an increased incidence of enterococcal bacteremia was seen September 2020—February 2021 (P < .0001) in hospitalized patients. A total of 5 unique Enterococcal strains among 13 bacteremia episodes were identified in patients with ICU beds in close proximity.

Conclusions:

A high incidence of enterococcal bacteremia was observed in critically ill patients with SARS-CoV-2, especially during surges. Contributing factors may include environmental contamination, patient colonization, nonadherence to infection control practices, resource limitations, ICU design and use of mechanical ventilation, central lines and immunosuppressants. MLST can be used to identify clusters to address these contributing factors.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© VA Healthcare Systems, Oklahoma City, 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Patient characteristics and risk factors for Enterococcal bacteremia

Figure 1

Table 2.Enterococcal species, total length of stay and 90-day all-cause mortality

Figure 2

Table 3.E. faecalis and E. faecium strain identification based on MLST

Figure 3

Figure 1.Geographical representation of patients located in the ICU that developed Enterococcal BSIs from specific enterococcal strains. Each color represents a unique strain.

Figure 4

Figure 2.Illustrates the number of patients hospitalized with SARS-CoV-2 infection (line) and the proportion (bar) of patients with both SARS-CoV-2 and Enterococcal BSIs among the ICU population over four, six-month time intervals.

Figure 5

Figure 3.Shows an increase in the number of blood cultures drawn and increase in those positive for Enterococcos species among hospitalized patients during COVID-19 surges over two years.

Supplementary material: File

Thind et al. supplementary material

Thind et al. supplementary material
Download Thind et al. supplementary material(File)
File 12.8 KB